Atossa Historical Cash Flow
| ATOS Stock | USD 0.84 0.03 3.45% |
Analysis of Atossa Genetics cash flow over time is an excellent tool to project Atossa Genetics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 470.4 K or Begin Period Cash Flow of 93 M as it is a great indicator of Atossa Genetics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Atossa Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atossa Genetics is a good buy for the upcoming year.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. About Atossa Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Atossa balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Atossa's non-liquid assets can be easily converted into cash.
Atossa Genetics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Atossa Genetics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Atossa Genetics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.At this time, Atossa Genetics' Change To Netincome is comparatively stable compared to the past year.
Atossa Genetics cash flow statement Correlations
Click cells to compare fundamentals
Atossa Genetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atossa Genetics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 27.0M | 96.8M | (25.5M) | (22.4K) | (17.4M) | (16.5M) | |
| Stock Based Compensation | 3.0M | 5.3K | 6.8K | 4.6M | 2.3M | 1.9M | |
| Free Cash Flow | (11.6M) | (16.5M) | (20.8M) | (21.0K) | (21.0M) | (20.0M) | |
| Change In Working Capital | (111.4K) | (1.2M) | (599K) | 1.5M | 448K | 470.4K | |
| Begin Period Cash Flow | 12.7M | 39.7M | 136.5M | 111K | 88.6M | 93.0M | |
| Other Cashflows From Financing Activities | 9.4M | 43.6M | (4.7M) | (14.0) | 3.7M | 5.3M | |
| Other Non Cash Items | 938.8K | 5.6M | 3K | 3.0M | 1.7M | 1.2M | |
| Capital Expenditures | 9.4K | 9K | 27K | 14.0 | 19K | 18.1K | |
| Total Cash From Operating Activities | (11.6M) | (16.5M) | (20.8M) | (20.9M) | (21.0M) | (20.0M) | |
| Net Income | (17.8M) | (20.6M) | (27.0M) | (30.1M) | (25.5M) | (24.2M) | |
| Total Cash From Financing Activities | 38.6M | 113.3M | 1K | (1.5K) | 3.7M | 3.5M | |
| End Period Cash Flow | 39.7M | 136.5M | 111M | 88.6K | 71.2M | 74.8M | |
| Change To Liabilities | (222.0K) | 1.3M | 128K | 2.4M | 2.8M | 2.9M | |
| Change To Inventory | (104.7K) | 437K | (329K) | 2.5M | 2.9M | 3.1M | |
| Depreciation | 52.8K | 46.5K | 23K | 8K | 17K | 16.2K | |
| Change To Account Receivables | 104.7K | (437K) | 329K | 743K | 854.5K | 897.2K | |
| Sale Purchase Of Stock | 12.3M | 11.3M | 9.6M | (573.0) | 0.0 | (1.5K) | |
| Total Cashflows From Investing Activities | (9.4K) | (9K) | (4.7M) | (14.0) | (19K) | (20.0K) | |
| Cash And Cash Equivalents Changes | 2.2M | 27.0M | 96.8M | (25.5M) | (29.3M) | (27.8M) | |
| Cash Flows Other Operating | 1.2M | (539.6K) | (1.6M) | (3.0M) | (2.7M) | (2.6M) | |
| Other Cashflows From Investing Activities | (7.6K) | (9.4K) | (9K) | (4.7K) | (5.4K) | (5.7K) | |
| Change To Netincome | 7.1M | 6.3M | 5.3M | 6.8M | 7.8M | 8.2M | |
| Change To Operating Activities | (731.1K) | (1.4M) | (1.3M) | (1.8M) | (1.7M) | (1.6M) | |
| Investments | (9.4K) | (9K) | (4.7M) | (2.0M) | (19K) | (20.0K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.